The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: April 2026

April 28, 2026
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.


5. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration

  • 1. The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis
  • 2. Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread
  • 3. A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival
  • 4. Humoral determinants of checkpoint immunotherapy
  • 5. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration
  • 6. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
  • 7. Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
  • 8. Respiratory viral infections awaken metastatic breast cancer cells in lungs
  • 9. DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth
Previous
Next
Wu, X., Huang S., Gao, J. et al. Science Advances. 11(34): eadv6937. (2025).
doi: 10.1126/sciadv.adv6937.
Summary by Jukka Westermarck, EACR Board Member

Summary of the findings

The authors discover a very sophisticated mechanism how cancer cell metabolism links to posttranslational protein modification (PTMs) by nitration and thereby inhibits MYC expression and cancer cell invasion. In detail, aldo-keto reductase AKR1B10, known to be downregulated in cancer, unrelated to its metabolic functions, nitrates a regulatory subunit of protein phosphatase 2A which leads to increased PP2A holoenzyme assembly and MYC inhibition. In cancer cells in which AKR1B10 is lost, pharmacological PP2A activation restores MYC suppression and effectively mitigates metastasis.
.
This paper is a fascinating example how yet very poorly understood PTM, such as single amino acid nitration, can have pivotal role in cancer by mechanisms that are completely hidden by genetics studies, but dependent on regulation of protein interaction and chains of PTMs such as here nitration leading to dephosphorylation and MYC inactivation.
.
Read more in Nature Science Advances

5. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration

  • 1. The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis
  • 2. Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread
  • 3. A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival
  • 4. Humoral determinants of checkpoint immunotherapy
  • 5. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration
  • 6. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
  • 7. Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
  • 8. Respiratory viral infections awaken metastatic breast cancer cells in lungs
  • 9. DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026

Erik Sahai, Principal Group Leader and Deputy Research Director at the Francis Crick Institute, travelled to Nanchang, China, this month to deliver an EACR keynote talk...

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

August 17, 2026

Nazha Ghaleb (who goes by Nana) has been an EACR member for over two years, and an EACR Ambassador for much of that time. A molecular...

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

August 12, 2026

EACR member Amel Aziba has now completed her EACR-Molecular Oncology Editorial Fellowship, funding that is awarded to enable a talented cancer researcher to gain knowledge and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

Spotlight on the Portuguese Association for Cancer Research (ASPIC)
Community

Spotlight on the Portuguese Association for Cancer Research (ASPIC)

August 27, 2026
EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference
Community

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR